Related Experiment Video

Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Antihypertensive drugs and central blood pressure

Carmel M McEniery1

  • 1Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital Box 110, Cambridge CB20QQ, United Kingdom. cmm41@cam.ac.uk

Current Hypertension Reports
|July 16, 2009
PubMed

Insights

Central blood pressure is a better predictor of cardiovascular risk than brachial pressure. Some blood pressure medications may affect central pressure differently than brachial pressure, requiring further investigation.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • Central blood pressure is increasingly recognized as a key determinant of cardiovascular risk, potentially more so than traditional brachial blood pressure measurements.
  • Antihypertensive medications exhibit varied effects on both brachial and central blood pressure, necessitating a deeper understanding of their specific impacts.

Purpose of the Study:

  • To investigate the differential effects of antihypertensive drugs on central versus brachial blood pressure.
  • To explore the clinical implications of these differential effects, particularly in relation to cardiovascular outcomes.

Main Methods:

  • Review of recent evidence and clinical studies examining central and brachial blood pressure.
  • Analysis of pharmacological data on the impact of various antihypertensive agents, including traditional beta-blockers like atenolol.

Main Results:

  • Evidence suggests central blood pressure is a more critical indicator of cardiovascular risk than brachial pressure.
  • Traditional beta-blockers, exemplified by atenolol, may negatively influence central blood pressure despite effectively reducing brachial blood pressure.

Conclusions:

  • The distinct effects of antihypertensive drugs on central pressure may explain outcomes observed in large clinical trials, such as those involving atenolol.
  • Further research is essential to determine if other antihypertensive classes offer benefits in lowering central blood pressure beyond their brachial pressure-lowering effects.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...